Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β
Open accessThe DOI matches its Crossref record; 169 of the 170 references it cites were found in a registry or an index.
Abstract
Metastasis of tumor cells from primary sites of malignancy to neighboring stromal tissue or distant localities entails in several instances, but not in every case, the epithelial-mesenchymal transition (EMT). EMT weakens the strong adhesion forces between differentiated epithelial cells so that carcinoma cells can achieve solitary or collective motility, which makes the EMT an intuitive mechanism for the initiation of tumor metastasis. EMT initiates after primary oncogenic events lead to secondary secretion of cytokines. The interaction between tumor-secreted cytokines and oncogenic stimuli facilitates EMT progression. A classic case of this mechanism is the cooperation between oncogenic Ras and the transforming growth factor β (TGFβ). The power of TGFβ to mediate EMT during metastasis depends on versatile signaling crosstalk and on the regulation of successive waves of expression of many other cytokines and the progressive remodeling of the extracellular matrix that facilitates motility through basement membranes. Since metastasis involves many organs in the body, whereas EMT affects carcinoma cell differentiation locally, it has frequently been debated whether EMT truly contributes to metastasis. Despite controversies, studies of circulating tumor cells, studies of acquired chemoresistance by metastatic cells, and several (but not all) metastatic animal models, support a link between EMT and metastasis, with TGFβ, often being a common denominator in this link. This article aims at discussing mechanistic cases where TGFβ signaling and EMT facilitate tumor cell dissemination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TGF-β1 plays a crucial role in promoting EMT, a key process involved in modulating alveolar epithelial cell plasticity [87,88].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [88]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Maitah, M. Y., Ali, S. S., Ahmad, A., Gadgeel, S. M., & Sarkar, F. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016068 · Cited by 142
RetractedShrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
Nieto, M. A., Huang, R. Y.-J., Jackson, R. A., & Thiery, J. P. (2016) · Cell · doi:10.1016/j.cell.2016.06.028 · Cited by 4,492
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
Metastatic colonization by circulating tumour cells
Massagué, J., & Obenauf, A. C. (2016) · Nature · doi:10.1038/nature17038 · Cited by 2,062 · cited 3×
“Once a primary tumor acquires invasive power in a primary site, malignant cells invade the blood vessels (intravasation) [123].”
BackgroundInfluentialZheng, X., Carstens, J. L., Kim, J., Scheible, M., Kaye, J., Sugimoto, H., Wu, C.-C., LeBleu, V. S., & Kalluri, R. (2015) · Nature · doi:10.1038/nature16064 · Cited by 2,032
Brabletz, T., Kalluri, R., Nieto, M. A., & Weinberg, R. A. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.118 · Cited by 1,961
Labelle, M., Begum, S., & Hynes, R. O. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.09.009 · Cited by 1,833
Fischer, K. R., Durrans, A., Lee, S., Sheng, J., Li, F., Wong, S. T. C., Choi, H., El Rayes, T., Ryu, S., Troeger, J., et al. (2015) · Nature · doi:10.1038/nature15748 · Cited by 1,791
Cited by
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
Liu, Z.-L., Chen, H.-H., Zheng, L.-L., Sun, L.-P., & Shi, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01460-1 · Cited by 1,300
Exosomes: key players in cancer and potential therapeutic strategy
Dai, J., Su, Y., Zhong, S., Cong, L., Liu, B., Yang, J., Tao, Y., He, Z., Chen, C., & Jiang, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00261-0 · Cited by 1,186
Advances on immunotherapy for osteosarcoma
Yu, S., & Yao, X. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02105-9 · Cited by 270
TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer
Hua, W., ten Dijke, P., Kostidis, S., Giera, M., & Hornsveld, M. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03398-6 · Cited by 238
TGF-beta: a master immune regulator
Larson, C., Oronsky, B., Carter, C. A., Oronsky, A., Knox, S. J., Sher, D., & Reid, T. R. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1744568 · Cited by 210
Transcriptional regulation of EMT transcription factors in cancer
Saitoh, M. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.10.001 · Cited by 162
Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis
Adekoya, T. O., & Richardson, R. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124449 · Cited by 170
Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies
Tanabe, S., Quader, S., Cabral, H., & Ono, R. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00904 · Cited by 161
Cancer-associated fibroblasts: The chief architect in the tumor microenvironment
Sarkar, M., Nguyen, T., Gundre, E., Ogunlusi, O., El-Sobky, M. H., Giri, B., & Sarkar, T. R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1089068 · Cited by 166
TGF-β signaling in cell fate control and cancer
Yu, Y., & Feng, X. (2019) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2019.07.007 · Cited by 138
The role of N6-methyladenosine mRNA in the tumor microenvironment
Li, M., Zha, X., & Wang, S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188522 · Cited by 123
Epithelial–Mesenchymal Transition (EMT)
Manfioletti, G., & Fedele, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411386 · Cited by 132
The critical role of platelet in cancer progression and metastasis
Zhou, L., Zhang, Z., Tian, Y., Li, Z., Liu, Z., & Zhu, S. (2023) · European journal of medical research · doi:10.1186/s40001-023-01342-w · Cited by 126
Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target
Franses, J. W., Philipp, J., Missios, P., Bhan, I., Liu, A., Yashaswini, C. N., Tai, E. C., Zhu, H., Ligorio, M., Nicholson, B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17150-3 · Cited by 93
Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents
Garrido-Navas, M. C., de Miguel‐Pérez, D., Expósito‐Hernández, J., Bayarri, C., Amezcua, V., Palomo, A. O., Valdivia, J., Guerrero, R., Puche, J. L. G., Lorente, J. A., et al. (2019) · Cells · doi:10.3390/cells8111382 · Cited by 79
p63 at the Crossroads between Stemness and Metastasis in Breast Cancer
Gatti, V., Bongiorno‐Borbone, L., Fierro, C., Annicchiarico‐Petruzzelli, M., Melino, G., & Peschiaroli, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112683 · Cited by 75
Fei, J., Fu, L., Cao, W., Hu, B., Zhao, H., & Li, J. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900229 · Cited by 70
The TGF-β Family in Glioblastoma
Cancela, I. G., & Caja, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021067 · Cited by 78
The Role of TGF-β Signaling Pathways in Cancer and Its Potential as a Therapeutic Target
Yang, Y., Ye, W.-L., Zhang, R., He, X., Wang, J., Liu, Y., Wang, Y., Yang, X., Zhang, Y., & Gan, W.-J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6675208 · Cited by 86
Factors Determining Epithelial-Mesenchymal Transition in Cancer Progression
Tomecka, P., Kunachowicz, D., Górczyńska, J., Gebuza, M., Kuźnicki, J., Skinderowicz, K., & Choromańska, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168972 · Cited by 70
Li, J., Chen, F., Peng, Y., Lv, Z., Lin, X., Chen, Z., & Wang, H. (2020) · Cells · doi:10.3390/cells9020296 · Cited by 61
Kozak, J., Forma, A., Czeczelewski, M., Kozyra, P., Sitarz, R., Radzikowska-Büchner, E., Sitarz, M., & Baj, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010277 · Cited by 63
Lipid metabolism reprogramming in colorectal cancer
Chen, D., Zhou, X., Yan, P., Yang, C., Li, Y., Han, L., & Ren, X. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30347 · Cited by 61
Zhu, J., Li, B., Xu, M., Liu, R., Xia, T., Zhang, Z., Xu, Y., & Liu, S. (2019) · ACS Nano · doi:10.1021/acsnano.9b07891 · Cited by 60
Transforming Growth Factor-β: An Agent of Change in the Tumor Microenvironment
Stuelten, C. H., & Zhang, Y. E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.764727 · Cited by 62
Yang, S., Sun, S., Xu, W., Yu, B., Wang, G., & Wang, H. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.10983 · Cited by 80
Ouyang, H., Du, A., Zhou, L., Zhang, T., Lü, B., Wang, Z., & Ji, L. (2022) · Phytotherapy Research · doi:10.1002/ptr.7401 · Cited by 53
Transforming Growth Factor-Beta (TGFβ) Signaling Pathway in Cholangiocarcinoma
Papoutsoglou, P., Louis, C., & Coulouarn, C. (2019) · Cells · doi:10.3390/cells8090960 · Cited by 52
Hisakane, K., Seike, M., Sugano, T., Yoshikawa, A., Matsuda, K., Takano, N., Takahashi, S., Noro, R., & Gemma, A. (2021) · Thoracic Cancer · doi:10.1111/1759-7714.13943 · Cited by 55
Apigenin in cancer therapy: From mechanism of action to nano-therapeutic agent
Zhou, Y., Yu, Y., Lv, H., Zhang, H., Liang, T., Zhou, G., Huang, L., Tian, Y., & Liang, W. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113385 · Cited by 49
Ramundo, V., Zanirato, G., & Aldieri, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212216 · Cited by 46
Vuoso, D. C., D’Angelo, S., Ferraro, R., Caserta, S., Guido, S., Cammarota, M., Porcelli, M., & Cacciapuoti, G. (2020) · Scientific Reports · doi:10.1038/s41598-020-73092-2 · Cited by 48
Migault, M., Sapkota, S., & Bracken, C. P. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04199-0 · Cited by 48
Turini, S., Bergandi, L., Gazzano, E., Prato, M., & Aldieri, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010150 · Cited by 44
PARP-1/2 Inhibitor Olaparib Prevents or Partially Reverts EMT Induced by TGF-β in NMuMG Cells
Schacke, M., Kumar, J., Colwell, N., Hermanson, K., Folle, G. A., Nechaev, S., Dhasarathy, A., & Lafon-Hughes, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030518 · Cited by 45
Zhang, X., Wang, L., Li, N., & Xiao, Y. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.02.031 · Cited by 44
Lee, S., Hu, Y., Loo, S. K., Tan, Y., Bhargava, R., Lewis, M. T., & Wang, X. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921333117 · Cited by 46
Colorectal Cancer Stem Cells in the Progression to Liver Metastasis
González-Villarreal, C. A., Quiroz-Reyes, A. G., Islas, J. F., & Garza-Treviño, E. N. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01511 · Cited by 43
Zhang, Z., & Xu, Y. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00509-1 · Cited by 47
Xu, Q., Cheng, D., Liu, Y., Pan, H., Li, G., Li, P., Yan, L., Sun, W., Ma, D., & Ni, C. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16758 · Cited by 45
NRP1 regulates radiation-induced EMT via TGF-β/Smad signaling in lung adenocarcinoma cells
Chen, Z., Gao, H., Dong, Z., Shen, Y., Wang, Z., Wei, W., Yi, J., Wang, R., Wu, N., & Jin, S. (2020) · International Journal of Radiation Biology · doi:10.1080/09553002.2020.1793015 · Cited by 39
The TGFβ Family in Human Placental Development at the Fetal-Maternal Interface
Lopes, S. M. C. D. S., Alexdóttir, M. S., & Valdimarsdóttir, G. (2020) · Biomolecules · doi:10.3390/biom10030453 · Cited by 43
New Insights into the Role of Sphingolipid Metabolism in Melanoma
Carrié, L., Virazels, M., Dufau, C., Montfort, A., Levade, T., Ségui, B., & Andrieu‐Abadie, N. (2020) · Cells · doi:10.3390/cells9091967 · Cited by 37
Cross-Talk between the TGF-β and Cell Adhesion Signaling Pathways in Cancer
Liao, J., Chen, R., Lin, B., Deng, R., Liang, Y., Zeng, J., Ma, S., & Qiu, X. (2024) · International Journal of Medical Sciences · doi:10.7150/ijms.96274 · Cited by 41
Ren, J., Wang, Y., Ware, T. M. B., Iaria, J., ten Dijke, P., & Zhu, H. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.07.042 · Cited by 35
Li, C., Wang, H., Fang, H., He, C., Pei, Y., & Gai, X. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10390 · Cited by 36
Fiorilla, I., Martinotti, S., Todesco, A. M., Bonsignore, G., Cavaletto, M., Patrone, M., Ranzato, E., & Audrito, V. (2023) · Cells · doi:10.3390/cells12162048 · Cited by 39
“TGF-β1 plays a crucial role in promoting EMT, a key process involved in modulating alveolar epithelial cell plasticity [87,88].”
BackgroundComparative Molecular Analysis of Cancer Behavior Cultured In Vitro, In Vivo, and Ex Vivo
Hum, N. R., Sebastian, A., Gilmore, S. F., He, W., Martin, K. A., Hinckley, A., Dubbin, K., Moya, M. L., Wheeler, E. K., Coleman, M. A., et al. (2020) · Cancers · doi:10.3390/cancers12030690 · Cited by 37
Niu, Q., Dong, Z., Liang, M., Luo, Y., Lin, H., Lin, M., Zhong, X., Yao, W., Weng, J., & Zhou, X. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01790-w · Cited by 33
RetractedBMP signaling is a therapeutic target in ovarian cancer
Fukuda, T., Fukuda, R., Tanabe, R., Koinuma, D., Koyama, H., Hashizume, Y., Moustakas, A., Miyazono, K., & Heldin, C. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00377-w · Cited by 35
Self-citationRole of exosomes in non-small cell lung cancer and EGFR-mutated lung cancer
Rao, D., Huang, D., Si, M.-Y., Lu, H., Tang, Z., & Zhang, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1142539 · Cited by 35
Wang, H., Wang, P., Xu, M. M., Song, X., Wu, H. M., Evert, M., Calvisi, D. F., Zeng, Y., & Chen, X. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03488-z · Cited by 36
Krüppel-like factors in tumors: Key regulators and therapeutic avenues
Zhang, Y., Yao, C., Ju, Z., Jiao, D., Hu, D., Li, Q., Liu, S., Wu, X., & Chen, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1080720 · Cited by 41
Targeting angiogenesis in gliomas: Potential role of phytochemicals
Sanati, M., Afshari, A. R., Amini, J., Mollazadeh, H., Jamialahmadi, T., & Sahebkar, A. (2022) · Journal of Functional Foods · doi:10.1016/j.jff.2022.105192 · Cited by 31
Feng, J., Li, C., Xu, R., Li, Y., Hou, Q., Feng, R., Wang, S., Zhang, L., & Li, C. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9762390 · Cited by 31
Yang, N., Gao, J., Hou, R., Xu, X., Yang, N., & Huang, S. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5564312 · Cited by 29
Bhatia, S., Monkman, J. H., Blick, T., Duijf, P. H. G., Nagaraj, S. H., & Thompson, E. W. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8081253 · Cited by 26
Li, J., Ke, J., Fang, J., & Chen, J. N. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29320 · Cited by 27
Liu, W., Li, W., Ma, S., Liang, L., Kou, Z.-Y., & Yang, J. H. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101011 · Cited by 24
Hai, Z., Wu, Y., & Ning, Z. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21220 · Cited by 26
Navigating the Cytokine Seas: Targeting Cytokine Signaling Pathways in Cancer Therapy
Stanilov, N., Velikova, T. V., & Stanilova, S. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021009 · Cited by 29
Emerging Roles for Browning of White Adipose Tissue in Prostate Cancer Malignant Behaviour
Álvarez-Artime, A., García-Soler, B., Sainz, R. M., & Mayo, J. C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115560 · Cited by 28
Osteosarcoma immune microenvironment: cellular struggle and novel therapeutic insights
Zhang, Y., Jiang, S., Lv, J., Feng, W., Yu, Y., & Zhao, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1584450 · Cited by 29
Jiménez-Salazar, J. E., Damián-Ferrara, R., Arteaga, M., Batina, N., & Damián‐Matsumura, P. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.631007 · Cited by 26
KLF3 is a crucial regulator of metastasis by controlling STAT3 expression in lung cancer
Sun, W., Hu, S., Zu, Y., & Deng, Y. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23072 · Cited by 22
Weidle, U. H., Birzele, F., & Nopora, A. (2019) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20149 · Cited by 22
Song, Y., Zhang, Y., Wang, X., Han, X., Shi, M., Xu, L., Yu, J., Zhang, L., & Han, S. (2022) · Brain Pathology · doi:10.1111/bpa.13217 · Cited by 23
Impact of Age-Related Genetic Differences on the Therapeutic Outcome of Papillary Thyroid Cancer
Kim, S., Kim, S. Y., Park, C. S., Chang, H., & Park, K. C. (2020) · Cancers · doi:10.3390/cancers12020448 · Cited by 21
Zhang, M., Zhou, K., Wang, Z., Liu, T., Stevens, L. E., Lynce, F. C., Chen, W. Y., Peng, S., Xie, Y., Zhai, D., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2640 · Cited by 22
TGFβ Signaling in the Tumor Microenvironment
Goulet, C. R., & Pouliot, F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-47189-7_6 · Cited by 22
Cheng, S., Wang, H., Kang, X., & Zhang, H. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16020251 · Cited by 21
Tsubakihara, Y., Ohata, Y., Okita, Y., Younis, S., Eriksson, J., Sellin, M. E., Ren, J., ten Dijke, P., Miyazono, K., Hikita, A., et al. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13215 · Cited by 20
Self-citationIn vitro cultures of circulating tumor cells: a potential tool to unravel drug sensitivity
Renzi, G. D., Marco, G. D., Meo, M. D., Rosso, E. D., Gazzaniga, P., & Nicolazzo, C. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2021.121 · Cited by 21
Role of TGF-β signaling in the mechanisms of tamoxifen resistance
Николаевна, Б. Н., Дронова, Т. А., Erdyneeva, D. B., Анатольевна, Г. П., & Чердынцева, Н. В. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.09.005 · Cited by 22
Park, M. N., Choi, J., Ribeiro, R. I. M. D. A., Delfino, D. V., Ko, S., & Kim, B. (2025) · Antioxidants · doi:10.3390/antiox14121474 · Cited by 19
Therapeutic Approaches for Metastases from Colorectal Cancer and Pancreatic Ductal Carcinoma
Quiroz-Reyes, A. G., Islas, J. F., González, P. D., Franco-Villareal, H., & Garza-Treviño, E. N. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13010103 · Cited by 16
Margaron, Y., Nagai, T., Guyon, L., Kurzawa, L., Morel, A., Pinheiro, A., Blanchoin, L., Reyal, F., Puisieux, A., & Théry, M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/797654 · Cited by 16
Hei, B., Liu, R., & Li, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27722 · Cited by 15
Du, F., Li, J., Zhong, X., Zhang, Z., & Zhao, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40118 · Cited by 20
A Snapshot of Cytokine Dynamics: A Fine Balance Between Health and Disease
Mallick, S., Duttaroy, A. K., & Bose, B. (2024) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30680 · Cited by 19
Coppola, A., Ilisso, C. P., Stellavato, A., Schiraldi, C., Caraglia, M., Mosca, L., Cacciapuoti, G., & Porcelli, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010286 · Cited by 15
Cerveró-Varona, A., Canciello, A., Peserico, A., Haidar-Montes, A. A., Citeroni, M. R., Mauro, A., Russo, V., Moffa, S., Pilato, S., Giacomo, S. D., et al. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100758 · Cited by 21
Nishizuka, M., Komada, R., & Imagawa, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194697 · Cited by 16
Exosomal non-coding RNAs-mediated EGFR-TKIs resistance in NSCLC with EGFR mutation
Cheng, D., Wang, B., Wu, L., Chen, R., Zhao, W., Fang, C., & Ji, M. (2023) · Medical Oncology · doi:10.1007/s12032-023-02125-3 · Cited by 18
Exosomes on the development and progression of renal fibrosis
Wang, P., Wu, C., Li, B., Yang, S., Li, W., Zhao, S., Ning, J., Zhou, X., & Fan, C. (2024) · Cell Proliferation · doi:10.1111/cpr.13677 · Cited by 15
Nozaki, M., & Nishizuka, M. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.06.004 · Cited by 14
Tao, B., Yi, C., Ma, Y., Li, Y., Zhang, B., Geng, Y., Chen, Z., Ma, X., & Chen, J. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10591-7 · Cited by 14
Unboxing the network among long non-coding RNAs and TGF-β signaling in cancer
Rodrigues‐Junior, D. M., & Moustakas, A. (2024) · Upsala Journal of Medical Sciences · doi:10.48101/ujms.v129.10614 · Cited by 14
Self-citationElevated high mobility group A2 expression in liver cancer predicts poor patient survival
Zhao, Y., Jiao, Y., Li, Y., Fu, Z., Yang, Z.-Y., & He, M. (2019) · Revista Española de Enfermedades Digestivas · doi:10.17235/reed.2019.6365/2019 · Cited by 13
miR-219-5p targets TBXT and inhibits breast cancer cell EMT and cell migration and invasion
Ye, Q., Wang, X., Yuan, M., Cui, S., Chen, Y., Hu, Z., Liu, D., Han, C., Li, B., & Chen, D. (2021) · Bioscience Reports · doi:10.1042/bsr20210318 · Cited by 13
RetractedSatoh, K., Sakai, S., & Nishizuka, M. (2022) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2022.101346 · Cited by 19
Shi, Q., Wu, H., Li, Y., Shen, L., Tian, X., Lin, T., & Wei, G. (2020) · BioMed Research International · doi:10.1155/2020/8039840 · Cited by 12
Yun, H. J., Kim, M., Kim, S. Y., Fang, S., Kim, Y., Chang, H., Chang, H., & Park, K. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020699 · Cited by 13
TGF-β-induced cell motility requires downregulation of ARHGAPs to sustain Rac1 activity
Motizuki, M., Koinuma, D., Yokoyama, T., Itoh, Y., Omata, C., Miyazono, K., Saitoh, M., & Miyazawa, K. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100545 · Cited by 11
Wu, Y., Can, J., Hao, S., Qiang, X., & Ning, Z. (2021) · Cerebrovascular Diseases · doi:10.1159/000518526 · Cited by 12
Arora, M., Kundu, A., Sinha, S., & Chosdol, K. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00769-9 · Cited by 12
Liver metastasis of colorectal cancer: Mechanism and clinical therapy (Review)
Yang, C., Zhao, L., Wang, C., Ye, Y., & Shen, Z. (2025) · Oncology Reports · doi:10.3892/or.2025.8963 · Cited by 11
Potential Therapeutic Agents against Paclitaxel—And Sorafenib-Resistant Papillary Thyroid Carcinoma
Kim, S., Park, K., Lim, J. H., Yun, H. J., Kim, S. Y., Choi, K. H., Kim, C. W., Lee, J. H., Weicker, R., Pan, C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810378 · Cited by 10
Homeobox C4 promotes hepatocellular carcinoma progression by the transactivation of Snail
Yang, T., Zhang, X., Li, X., Sun, M.-Z., & Gao, P.-Z. (2020) · Neoplasma · doi:10.4149/neo_2020_200403n350 · Cited by 10
Feng, S., Tong, H., Gao, J., Tang, S., Yang, W., Wang, G.-M., Zhou, H., & Wen, S. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10647 · Cited by 12
Metadata
- Authors
- Tsubakihara, Y., & Moustakas, A.
- Affiliations
- Uppsala University (SE)
- Corresponding author
- Moustakas, Aristidis
- ORCID
- Moustakas, Aristidis
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-11-20
- Volume
- 19
- Issue
- 11
- Pages
- 3672
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6274739
- OpenAlex
- W2900585188
- Cited by
- 160
- References
- 170
- Citations by year
- 2026: 8 · 2025: 10 · 2024: 21 · 2023: 22 · 2022: 22 · 2021: 31 · 2020: 29 · 2019: 17
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ludwig Institute for Cancer Research (Uppsala Branch)
- Cancerfonden (CAN 2015/438)
- Vetenskapsrådet (K2013-66X-14936-10-5 to AM)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- epithelial-mesenchymal transition, metastasis, TGF-beta, TGF-beta signaling, oncogenic Ras, cytokine signaling, signaling crosstalk, extracellular matrix remodeling, collective cell migration, circulating tumor cells, chemoresistance, tumor cell dissemination
- MeSH terms
- Animals, Humans, Models, Biological, Neoplasm Metastasis, Transcription Factors, Signal Transduction, Transforming Growth Factor beta, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.